TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs10952890
log Bayes Factor = 0.2076
Chromosome 7   position 86,355,215  (GRCh37) Explore rs10952890 on Ensembl!
Variant rs10952890 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
K80 Cholelithiasis
0.259 0.741 0.000
K80.2 Calculus of gallbladder without cholecystitis
0.255 0.745 0.000
K80.5 Calculus of bile duct without cholangitis or cholecystitis
0.251 0.749 0.000
K80-K87 Disorders of gallbladder, biliary tract and pancreas
0.247 0.753 0.000
K81 Cholecystitis
0.240 0.760 0.000
K82 Other diseases of gallbladder
0.225 0.775 0.000
K81.0 Acute cholecystitis
0.224 0.776 0.000
K80.0 Calculus of gallbladder with acute cholecystitis
0.218 0.782 0.000
K82.8 Other specified diseases of gallbladder
0.216 0.784 0.000
K83 Other diseases of biliary tract
0.212 0.788 0.000
K81.9 Cholecystitis, unspecified
0.210 0.790 0.000
K80.4 Calculus of bile duct with cholecystitis
0.207 0.793 0.000
K85 Acute pancreatitis
0.197 0.803 0.000
K83.1 Obstruction of bile duct
0.194 0.806 0.000
K80.3 Calculus of bile duct with cholangitis
0.186 0.814 0.000
K81.1 Chronic cholecystitis
0.184 0.816 0.000
K81.8 Other cholecystitis
0.180 0.820 0.000
K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere
0.177 0.823 0.000
K82.2 Perforation of gallbladder
0.171 0.829 0.000
K83.9 Disease of biliary tract, unspecified
0.164 0.836 0.000
K82.1 Hydrops of gallbladder
0.161 0.839 0.000
K82.0 Obstruction of gallbladder
0.158 0.842 0.000
K82.3 Fistula of gallbladder
0.157 0.843 0.000
K83.5 Biliary cyst
0.157 0.843 0.000
K83.2 Perforation of bile duct
0.156 0.844 0.000
K80.8 Other cholelithiasis
0.155 0.845 0.000
K83.0 Cholangitis
0.148 0.852 0.000
K85.1 Biliary acute pancreatitis
0.148 0.852 0.000
K80.1 Calculus of gallbladder with other cholecystitis
0.147 0.853 0.000
K85.0 Idiopathic acute pancreatitis
0.147 0.853 0.000
K85.8 Other acute pancreatitis
0.147 0.853 0.000
K83.4 Spasm of sphincter of Oddi
0.146 0.854 0.000
K85.3 Drug-induced acute pancreatitis
0.145 0.855 0.000
K85.2 Alcohol-induced acute pancreatitis
0.144 0.856 0.000
K83.3 Fistula of bile duct
0.141 0.859 0.000
K82.4 Cholesterolosis of gallbladder
0.140 0.860 0.000
K85.9 Acute pancreatitis, unspecified
0.140 0.860 0.000
K82.9 Disease of gallbladder, unspecified
0.139 0.861 0.000
K80.36 Calculus of bile duct with acute and chronic cholangitis without obstruction
0.133 0.867 0.000
K83.8 Other specified diseases of biliary tract
0.128 0.872 0.000
K87.1 Disorders of pancreas in diseases classified elsewhere
0.127 0.873 0.000
K87.0 Disorders of gallbladder and biliary tract in diseases classified elsewhere
0.127 0.873 0.000
K86 Other diseases of pancreas
0.057 0.943 0.001
N92.0 Excessive and frequent menstruation with regular cycle
0.000 0.951 0.049
O48 Prolonged pregnancy
0.000 0.952 0.048
Z88.6 Personal history of allergy to analgesic agent
0.044 0.956 0.000
K86.8 Other specified diseases of pancreas
0.038 0.961 0.000
K86.2 Cyst of pancreas
0.037 0.963 0.001
K86.0 Alcohol-induced chronic pancreatitis
0.037 0.963 0.001
K86.9 Disease of pancreas, unspecified
0.033 0.966 0.001
N92 Excessive, frequent and irregular menstruation
0.000 0.968 0.032
K86.1 Other chronic pancreatitis
0.031 0.968 0.001
N92.1 Excessive and frequent menstruation with irregular cycle
0.000 0.971 0.029
N92.3 Ovulation bleeding
0.000 0.974 0.026
K86.3 Pseudocyst of pancreas
0.025 0.974 0.001
N92.5 Other specified irregular menstruation
0.000 0.975 0.025
N92.4 Excessive bleeding in the premenopausal period
0.000 0.975 0.025
N92.2 Excessive menstruation at puberty
0.000 0.977 0.023
M54.59 Low back pain (Site unspecified)
0.017 0.983 0.000
M54.5 Low back pain
0.016 0.984 0.000
N92.6 Irregular menstruation, unspecified
0.000 0.985 0.014
M54.57 Low back pain (Lumbosacral region)
0.014 0.986 0.000
M54.50 Low back pain (Multiple sites in spine)
0.013 0.987 0.000
M54.58 Low back pain (Sacral and sacrococcygeal region)
0.013 0.987 0.000
M54.56 Low back pain (Lumbar region)
0.013 0.987 0.000
M54.55 Low back pain (Thoracolumbar region)
0.013 0.987 0.000
M54.52 Low back pain-Cervical
0.012 0.988 0.000
M54.54 Low back pain-Thoracic
0.012 0.988 0.000
M54.53 Low back pain-Cervicothoracic
0.012 0.988 0.000
M54.51 Low back pain-Occipit-atl-axl
0.012 0.988 0.000
E83.5 Disorders of calcium metabolism
0.000 0.990 0.010
K21.9 Gastro-oesophageal reflux disease without oesophagitis
0.010 0.990 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.991 0.009
N30.9 Cystitis, unspecified
0.009 0.991 0.000
R14 Flatulence and related conditions
0.008 0.992 0.000
G35 Multiple sclerosis
0.007 0.993 0.000
C85.1 B-cell lymphoma, unspecified
0.007 0.993 0.000
M54 Dorsalgia
0.007 0.993 0.000
N30.2 Other chronic cystitis
0.006 0.994 0.000
N30 Cystitis
0.006 0.994 0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.006 0.994 0.000
D18.0 Haemangioma, any site
0.000 0.994 0.006
M54.3 Sciatica
0.006 0.994 0.000
M54.36 Sciatica (Lumbar region)
0.006 0.994 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.994 0.006
M54.4 Lumbago with sciatica
0.005 0.994 0.000
N30.3 Trigonitis
0.005 0.995 0.000
C50.4 Upper-outer quadrant of breast
0.000 0.995 0.005
M54.6 Pain in thoracic spine
0.005 0.995 0.000
C85.7 Other specified types of non-Hodgkin's lymphoma
0.005 0.995 0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.005 0.995 0.000
M54.8 Other dorsalgia
0.005 0.995 0.000
K76 Other diseases of liver
0.005 0.995 0.000
K76.8 Other specified diseases of liver
0.005 0.995 0.000
M54.0 Panniculitis affecting regions of neck and back
0.005 0.995 0.000
K74 Fibrosis and cirrhosis of liver
0.005 0.995 0.000
H65.3 Chronic mucoid otitis media
0.000 0.995 0.005
H66.3 Other chronic suppurative otitis media
0.000 0.995 0.005
K74.6 Other and unspecified cirrhosis of liver
0.005 0.995 0.000
K70-K77 Diseases of liver
0.005 0.995 0.000
N30.8 Other cystitis
0.005 0.995 0.000
M54.37 Sciatica (Lumbosacral region)
0.005 0.995 0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.005 0.995 0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.005 0.995 0.000
S62.60 Fracture of other finger (closed)
0.000 0.995 0.005
I35.0 Aortic (valve) stenosis
0.005 0.995 0.000
C83 Diffuse non-Hodgkin's lymphoma
0.005 0.995 0.000
K76.9 Liver disease, unspecified
0.005 0.995 0.000
N18.3 Chronic kidney disease, stage 3
0.000 0.995 0.005
M54.47 Lumbago with sciatica (Lumbosacral region)
0.004 0.995 0.000
C85.0 Lymphosarcoma
0.004 0.995 0.000
T43.6 Psychostimulants with abuse potential
0.000 0.995 0.004
H66 Suppurative and unspecified otitis media
0.000 0.995 0.005
M54.35 Sciatica (Thoracolumbar region)
0.004 0.995 0.000
M54.34 Sciatica-Thoracic
0.004 0.995 0.000
M54.33 Sciatica-Cervicothoracic
0.004 0.995 0.000
M54.32 Sciatica-Cervical
0.004 0.995 0.000
M54.31 Sciatica-Occipit-atl-axl
0.004 0.995 0.000
T43.9 Psychotropic drug, unspecified
0.000 0.995 0.004
M54.30 Sciatica (Multiple sites in spine)
0.004 0.996 0.000
M54.2 Cervicalgia
0.004 0.996 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.996 0.004
N30.1 Interstitial cystitis (chronic)
0.004 0.996 0.000
K74.0 Hepatic fibrosis
0.004 0.996 0.000
K72 Hepatic failure, not elsewhere classified
0.004 0.996 0.000
M54.49 Lumbago with sciatica (Site unspecified)
0.004 0.996 0.000
M54.38 Sciatica (Sacral and sacrococcygeal region)
0.004 0.996 0.000
C83.3 Large cell (diffuse)
0.004 0.996 0.000
K76.7 Hepatorenal syndrome
0.004 0.996 0.000
E03.9 Hypothyroidism, unspecified
0.000 0.996 0.004
T42.4 Benzodiazepines
0.000 0.996 0.004
N30.4 Irradiation cystitis
0.004 0.996 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.996 0.004
H65 Nonsuppurative otitis media
0.000 0.996 0.004
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.996 0.004
M54.48 Lumbago with sciatica (Sacral and sacrococcygeal region)
0.004 0.996 0.000
M54.45 Lumbago with sciatica (Thoracolumbar region)
0.004 0.996 0.000
M54.44 Lumbago with sciatica-Thoracic
0.004 0.996 0.000
M54.43 Lumbago with sciatica-Cervicothoracic
0.004 0.996 0.000
M54.42 Lumbago with sciatica-Cervical
0.004 0.996 0.000
M54.41 Lumbago with sciatica-Occipit-atl-axl
0.004 0.996 0.000
M54.40 Lumbago with sciatica (Multiple sites in spine)
0.004 0.996 0.000
M54.46 Lumbago with sciatica (Lumbar region)
0.004 0.996 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.996 0.004
M54.65 Pain in thoracic spine (Thoracolumbar region)
0.004 0.996 0.000
M54.63 Pain in thoracic spine (Cervicothoracic region)
0.004 0.996 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.996 0.004
K74.5 Biliary cirrhosis, unspecified
0.004 0.996 0.000
R06.5 Mouth breathing
0.000 0.996 0.004
C95 Leukaemia of unspecified cell type
0.004 0.996 0.000
N18 Chronic renal failure
0.000 0.996 0.004
M54.88 Other dorsalgia (Sacral and sacrococcygeal region)
0.004 0.996 0.000
M54.80 Other dorsalgia (Multiple sites in spine)
0.004 0.996 0.000
N30.0 Acute cystitis
0.004 0.996 0.000
K75 Other inflammatory liver diseases
0.004 0.996 0.000
M54.87 Other dorsalgia (Lumbosacral region)
0.004 0.996 0.000
H65-H75 Diseases of middle ear and mastoid
0.000 0.996 0.004
K76.3 Infarction of liver
0.004 0.996 0.000
C84 Peripheral and cutaneous T-cell lymphomas
0.004 0.996 0.000
K73 Chronic hepatitis, not elsewhere classified
0.004 0.996 0.000
M54.69 Pain in thoracic spine-Site unspe
0.004 0.996 0.000
M54.68 Pain in thoracic spine-Sacral/sacrococ
0.004 0.996 0.000
M54.67 Pain in thoracic spine-Lumbosacral
0.004 0.996 0.000
M54.66 Pain in thoracic spine-Lumbar
0.004 0.996 0.000
M54.64 Pain in thoracic spine (Thoracic region)
0.004 0.996 0.000
M54.62 Pain in thoracic spine-Cervical
0.004 0.996 0.000
M54.61 Pain in thoracic spine-Occipit-atl-axl
0.004 0.996 0.000
M54.60 Pain in thoracic spine (Multiple sites in spine)
0.004 0.996 0.000
K71 Toxic liver disease
0.004 0.996 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.996 0.004
M54.86 Other dorsalgia (Lumbar region)
0.004 0.996 0.000
K74.1 Hepatic sclerosis
0.004 0.996 0.000
N18.5 Chronic kidney disease, stage 5
0.000 0.996 0.004
M54.85 Other dorsalgia (Thoracolumbar region)
0.004 0.996 0.000
M54.83 Other dorsalgia (Cervicothoracic region)
0.004 0.996 0.000
M54.82 Other dorsalgia (Cervical region)
0.004 0.996 0.000
M54.81 Other dorsalgia (Occipito-atlanto-axial region)
0.004 0.996 0.000
C92 Myeloid leukaemia
0.004 0.996 0.000
C91 Lymphoid leukaemia
0.004 0.996 0.000
K76.5 Hepatic veno-occlusive disease
0.004 0.996 0.000
K76.4 Peliosis hepatis
0.004 0.996 0.000
K76.2 Central haemorrhagic necrosis of liver
0.004 0.996 0.000
M54.84 Other dorsalgia (Thoracic region)
0.004 0.996 0.000
M54.09 Panniculitis affecting regions of neck and back (Site unspecified)
0.004 0.996 0.000
M54.08 Panniculitis affecting regions of neck and back (Sacral and sacrococcygeal region)
0.004 0.996 0.000
M54.07 Panniculitis affecting regions of neck and back (Lumbosacral region)
0.004 0.996 0.000
M54.06 Panniculitis affecting regions of neck and back (Lumbar region)
0.004 0.996 0.000
M54.05 Panniculitis affecting regions of neck and back (Thoracolumbar region)
0.004 0.996 0.000
M54.04 Panniculitis affecting regions of neck and back (Thoracic region)
0.004 0.996 0.000
M54.03 Panniculitis affecting regions of neck and back (Cervicothoracic region)
0.004 0.996 0.000
M54.02 Panniculitis affecting regions of neck and back (Cervical region)
0.004 0.996 0.000
M54.01 Panniculitis affecting regions of neck and back (Occipito-atlanto-axial region)
0.004 0.996 0.000
M54.00 Panniculitis affecting regions of neck and back (Multiple sites in spine)
0.004 0.996 0.000
K74.4 Secondary biliary cirrhosis
0.004 0.996 0.000
K74.2 Hepatic fibrosis with hepatic sclerosis
0.004 0.996 0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.996 0.004
G35-G37 Demyelinating diseases of the central nervous system
0.004 0.996 0.000
H66.1 Chronic tubotympanic suppurative otitis media
0.000 0.996 0.004
K72.0 Acute and subacute hepatic failure
0.004 0.996 0.000
C86 Other specified types of T/NK-cell lymphoma
0.004 0.996 0.000
N18.4 Chronic kidney disease, stage 4
0.000 0.996 0.004
C83.1 Small cleaved cell (diffuse)
0.004 0.996 0.000
K76.1 Chronic passive congestion of liver
0.004 0.996 0.000
C93 Monocytic leukaemia
0.004 0.996 0.000
K75.0 Abscess of liver
0.004 0.996 0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.004 0.996 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.996 0.004
H66.2 Chronic atticoantral suppurative otitis media
0.000 0.996 0.004
K77 Liver disorders in diseases classified elsewhere
0.004 0.996 0.000
M54.89 Other dorsalgia (Site unspecified)
0.003 0.996 0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.004 0.996 0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.004 0.996 0.000
C94 Other leukaemias of specified cell type
0.004 0.996 0.000
C81 Hodgkin's disease
0.004 0.996 0.000
C83.7 Burkitt's tumour
0.004 0.996 0.000
H65.9 Nonsuppurative otitis media, unspecified
0.000 0.996 0.004
M54.9 Dorsalgia, unspecified
0.004 0.996 0.000
M54.39 Sciatica (Site unspecified)
0.004 0.996 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.996 0.003
C90 Multiple myeloma and malignant plasma cell neoplasms
0.004 0.996 0.000
H72 Perforation of tympanic membrane
0.000 0.996 0.004
C83.2 Mixed small and large cell (diffuse)
0.004 0.996 0.000
K74.3 Primary biliary cirrhosis
0.004 0.996 0.000
C83.6 Undifferentiated (diffuse)
0.003 0.996 0.000
C83.4 Immunoblastic (diffuse)
0.003 0.996 0.000
K72.9 Hepatic failure, unspecified
0.003 0.996 0.000
H73 Other disorders of tympanic membrane
0.000 0.996 0.004
M54.28 Cervicalgia-Sacral/sacrococ
0.003 0.996 0.000
K76.0 Fatty (change of) liver, not elsewhere classified
0.004 0.996 0.000
K72.1 Chronic hepatic failure
0.003 0.996 0.000
T40.2 Other opioids
0.000 0.996 0.004
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.996 0.003
C83.5 Lymphoblastic (diffuse)
0.003 0.996 0.000
H66.9 Otitis media, unspecified
0.000 0.996 0.003
T36 Poisoning by systemic antibiotics
0.000 0.996 0.003
N18.8 Other chronic renal failure
0.000 0.996 0.003
M54.29 Cervicalgia-Site unspe
0.003 0.996 0.000
M54.1 Radiculopathy
0.003 0.996 0.000
H69 Other disorders of Eustachian tube
0.000 0.996 0.003
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.996 0.003
M54.27 Cervicalgia-Lumbosacral
0.003 0.997 0.000
M54.26 Cervicalgia-Lumbar
0.003 0.997 0.000
M54.25 Cervicalgia-Thoracolumbar
0.003 0.997 0.000
M54.24 Cervicalgia-Thoracic
0.003 0.997 0.000
M54.20 Cervicalgia-Mult site
0.003 0.997 0.000
H66.4 Suppurative otitis media, unspecified
0.000 0.997 0.003
C95.9 Leukaemia, unspecified
0.003 0.997 0.000
H66.0 Acute suppurative otitis media
0.000 0.997 0.003
T43.2 Other and unspecified antidepressants
0.000 0.997 0.003
Z60.2 Living alone
0.000 0.997 0.003
M54.23 Cervicalgia (Cervicothoracic region)
0.003 0.997 0.000
M54.21 Cervicalgia (Occipito-atlanto-axial region)
0.003 0.997 0.000
K76.6 Portal hypertension
0.003 0.997 0.000
K73.9 Chronic hepatitis, unspecified
0.003 0.997 0.000
G37 Other demyelinating diseases of central nervous system
0.003 0.997 0.000
H73.8 Other specified disorders of tympanic membrane
0.000 0.997 0.003
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.003 0.997 0.000
N18.9 Chronic renal failure, unspecified
0.000 0.997 0.003
C83.0 Small cell (diffuse)
0.003 0.997 0.000
K75.8 Other specified inflammatory liver diseases
0.003 0.997 0.000
C84.5 Other and unspecified T-cell lymphomas
0.003 0.997 0.000
H65.0 Acute serous otitis media
0.000 0.997 0.003
H72.0 Central perforation of tympanic membrane
0.000 0.997 0.003
C88 Malignant immunoproliferative diseases
0.003 0.997 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.997 0.003
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.997 0.003
C81.1 Nodular sclerosis
0.003 0.997 0.000
C91.1 Chronic lymphocytic leukaemia
0.003 0.997 0.000
N18.0 End-stage renal disease
0.000 0.997 0.003
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.997 0.003
C84.8 Cutaneous T-cell lymphoma, unspecified
0.003 0.997 0.000
C95.1 Chronic leukaemia of unspecified cell type
0.003 0.997 0.000
K73.8 Other chronic hepatitis, not elsewhere classified
0.003 0.997 0.000
H68 Eustachian salpingitis and obstruction
0.000 0.997 0.003
C91.5 Adult T-cell leukaemia
0.003 0.997 0.000
C91.0 Acute lymphoblastic leukaemia
0.003 0.997 0.000
K71.1 Toxic liver disease with hepatic necrosis
0.003 0.997 0.000
K71.0 Toxic liver disease with cholestasis
0.003 0.997 0.000
M54.94 Dorsalgia, unspecified (Thoracic region)
0.003 0.997 0.000
C84.0 Mycosis fungoides
0.003 0.997 0.000
C90.2 Plasmacytoma, extramedullary
0.003 0.997 0.000
H65.1 Other acute nonsuppurative otitis media
0.000 0.997 0.003
H72.9 Perforation of tympanic membrane, unspecified
0.000 0.997 0.003
K71.9 Toxic liver disease, unspecified
0.003 0.997 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.997 0.003
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.997 0.003
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.997 0.003
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.997 0.003
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.997 0.003
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.997 0.003
T44.0 Anticholinesterase agents
0.000 0.997 0.003
C92.5 Acute myelomonocytic leukaemia
0.003 0.997 0.000
C92.1 Chronic myeloid leukaemia
0.003 0.997 0.000
C95.7 Other leukaemia of unspecified cell type
0.003 0.997 0.000
C95.2 Subacute leukaemia of unspecified cell type
0.003 0.997 0.000
C95.0 Acute leukaemia of unspecified cell type
0.003 0.997 0.000
H65.2 Chronic serous otitis media
0.000 0.997 0.003
K75.2 Nonspecific reactive hepatitis
0.003 0.997 0.000
K75.1 Phlebitis of portal vein
0.003 0.997 0.000
T42.1 Iminostilbenes
0.000 0.997 0.003
H75 Other disorders of middle ear and mastoid in diseases classified elsewhere
0.000 0.997 0.003
H67 Otitis media in diseases classified elsewhere
0.000 0.997 0.003
M81.90 Osteoporosis, unspecified (Multiple sites)
0.000 0.997 0.003
C84.9 Mature T/NK-cell lymphoma, unspecified
0.003 0.997 0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.003 0.997 0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.003 0.997 0.000
C84.3 Lymphoepithelioid lymphoma
0.003 0.997 0.000
C84.2 T-zone lymphoma
0.003 0.997 0.000
C84.1 Sezary's diease
0.003 0.997 0.000
C92.2 Subacute myeloid leukaemia
0.003 0.997 0.000
H69.8 Other specified disorders of Eustachian tube
0.000 0.997 0.003
K73.1 Chronic lobular hepatitis, not elsewhere classified
0.003 0.997 0.000
K73.0 Chronic persistent hepatitis, not elsewhere classified
0.003 0.997 0.000
C86.5 Angioimmunoblastic T-cell lymphoma
0.003 0.997 0.000
C92.0 Acute myeloid leukaemia
0.003 0.997 0.000
K71.8 Toxic liver disease with other disorders of liver
0.003 0.997 0.000
K71.7 Toxic liver disease with fibrosis and cirrhosis of liver
0.003 0.997 0.000
K71.6 Toxic liver disease with hepatitis, not elsewhere classified
0.003 0.997 0.000
K71.5 Toxic liver disease with chronic active hepatitis
0.003 0.997 0.000
K71.4 Toxic liver disease with chronic lobular hepatitis
0.003 0.997 0.000
K71.3 Toxic liver disease with chronic persistent hepatitis
0.003 0.997 0.000
K71.2 Toxic liver disease with acute hepatitis
0.003 0.997 0.000
C92.7 Other myeloid leukaemia
0.003 0.997 0.000
G36 Other acute disseminated demyelination
0.003 0.997 0.000
C91.8 Mature B-cell leukaemia Burkitt-type
0.003 0.997 0.000
C91.7 Other lymphoid leukaemia
0.003 0.997 0.000
C91.6 Prolymphocytic leukaemia of T-cell type
0.003 0.997 0.000
C91.3 Prolymphocytic leukaemia
0.003 0.997 0.000
C91.2 Subacute lymphocytic leukaemia
0.003 0.997 0.000
C92.9 Myeloid leukaemia, unspecified
0.003 0.997 0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.003 0.997 0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.003 0.997 0.000
C92.3 Myeloid sarcoma
0.003 0.997 0.000
H65.4 Other chronic nonsuppurative otitis media
0.000 0.997 0.003
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.997 0.003
K75.4 Autoimmune hepatitis
0.003 0.997 0.000
K75.3 Granulomatous hepatitis, not elsewhere classified
0.003 0.997 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.997 0.003
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.997 0.003
C84.4 Peripheral T-cell lymphoma
0.003 0.997 0.000
C92.4 Acute promyelocytic leukaemia
0.003 0.997 0.000
C93.1 Chronic monocytic leukaemia
0.003 0.997 0.000
G37.9 Demyelinating disease of central nervous system, unspecified
0.003 0.997 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.997 0.003
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.997 0.003
M54.17 Radiculopathy (Lumbosacral region)
0.003 0.997 0.000
M54.95 Dorsalgia, unspecified (Thoracolumbar region)
0.003 0.997 0.000
T36.3 Macrolides
0.000 0.997 0.003
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.997 0.003
T42.2 Succinimides and oxazolidinediones
0.000 0.997 0.003
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.997 0.003
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.003 0.997 0.000
C86.4 Blastic NK-cell lymphoma
0.003 0.997 0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.003 0.997 0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.003 0.997 0.000
C86.1 Hepatosplenic T-cell lymphoma
0.003 0.997 0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.003 0.997 0.000
M54.93 Dorsalgia, unspecified (Cervicothoracic region)
0.003 0.997 0.000
C91.9 Lymphoid leukaemia, unspecified
0.003 0.997 0.000
C94.4 Acute panmyelosis
0.003 0.997 0.000
N18.1 Chronic kidney disease, stage 1
0.000 0.997 0.003
H71 Cholesteatoma of middle ear
0.000 0.997 0.003
C93.9 Monocytic leukaemia, unspecified
0.003 0.997 0.000
C93.7 Other monocytic leukaemia
0.003 0.997 0.000
C93.3 Juvenile myelomonocytic leukaemia
0.003 0.997 0.000
C93.2 Subacute monocytic leukaemia
0.003 0.997 0.000
C93.0 Acute monocytic leukaemia
0.003 0.997 0.000
H72.1 Attic perforation of tympanic membrane
0.000 0.997 0.003
K73.2 Chronic active hepatitis, not elsewhere classified
0.003 0.997 0.000
K77.0 Liver disorders in infectious and parasitic diseases classified elsewhere
0.003 0.997 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.997 0.003
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.997 0.003
M54.98 Dorsalgia, unspecified (Sacral and sacrococcygeal region)
0.003 0.997 0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.003 0.997 0.000
C81.3 Lymphocytic depletion
0.003 0.997 0.000
C94.7 Other specified leukaemias
0.003 0.997 0.000
C94.5 Acute myelofibrosis
0.003 0.997 0.000
C94.3 Mast cell leukaemia
0.003 0.997 0.000
C94.2 Acute megakaryoblastic leukaemia
0.003 0.997 0.000
C94.1 Chronic erythraemia
0.003 0.997 0.000
C94.0 Acute erythraemia and erythroleukaemia
0.003 0.997 0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.003 0.997 0.000
C96.8 Histiocytic sarcoma
0.003 0.997 0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.003 0.997 0.000
C96.6 Unifocal Langerhans-cell histiocytosis
0.003 0.997 0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.003 0.997 0.000
C96.4 Sarcoma of dendritic cells (accessory cells)
0.003 0.997 0.000
C96.3 True histiocytic lymphoma
0.003 0.997 0.000
C96.2 Malignant mast cell tumour
0.003 0.997 0.000
C96.1 Malignant histiocytosis
0.003 0.997 0.000
C96.0 Letterer-Siwe disease
0.003 0.997 0.000
T42.3 Barbiturates
0.000 0.997 0.003
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.997 0.003
M54.91 Dorsalgia, unspecified (Occipito-atlanto-axial region)
0.003 0.997 0.000
C90.1 Plasma cell leukaemia
0.003 0.997 0.000
M54.92 Dorsalgia, unspecified (Cervical region)
0.003 0.997 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.997 0.003
C91.4 Hairy-cell leukaemia
0.003 0.997 0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.003 0.997 0.000
K77.8 Liver disorders in other diseases classified elsewhere
0.003 0.997 0.000
R09.1 Pleurisy
0.000 0.997 0.003
C81.9 Hodgkin's disease, unspecified
0.003 0.997 0.000
C81.0 Lymphocytic predominance
0.003 0.997 0.000
H73.0 Acute myringitis
0.000 0.997 0.003
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.003 0.997 0.000
K70 Alcoholic liver disease
0.003 0.997 0.000
T36.8 Other systemic antibiotics
0.000 0.997 0.003
T36.0 Penicillins
0.000 0.997 0.003
C81.7 Other Hodgkin's disease
0.003 0.997 0.000
T36.4 Tetracyclines
0.000 0.997 0.003
M54.18 Radiculopathy (Sacral and sacrococcygeal region)
0.003 0.997 0.000
M54.13 Radiculopathy (Cervicothoracic region)
0.003 0.997 0.000
G37.8 Other specified demyelinating diseases of central nervous system
0.003 0.997 0.000
T36.9 Systemic antibiotic, unspecified
0.000 0.997 0.003
T36.7 Antifungal antibiotics, systemically used
0.000 0.997 0.003
T36.6 Rifamycins
0.000 0.997 0.003
T36.5 Aminoglycosides
0.000 0.997 0.003
T36.2 Chloramphenicol group
0.000 0.997 0.003
E83 Disorders of mineral metabolism
0.000 0.997 0.003
M54.15 Radiculopathy (Thoracolumbar region)
0.002 0.997 0.000
M54.11 Radiculopathy (Occipito-atlanto-axial region)
0.002 0.997 0.000
C82.2 Large cell, follicular
0.003 0.997 0.000
H72.2 Other marginal perforations of tympanic membrane
0.000 0.997 0.003
H73.9 Disorder of tympanic membrane, unspecified
0.000 0.997 0.003
H69.0 Patulous Eustachian tube
0.000 0.997 0.003
I51.8 Other ill-defined heart diseases
0.000 0.997 0.003
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.997 0.003
T40.8 Lysergide [LSD]
0.000 0.997 0.003
T40.7 Cannabis (derivatives)
0.000 0.997 0.003
T40.5 Cocaine
0.000 0.997 0.003
T40.0 Opium
0.000 0.997 0.003
T42.0 Hydantoin derivatives
0.000 0.997 0.003
M54.97 Dorsalgia, unspecified (Lumbosacral region)
0.003 0.997 0.000
C81.2 Mixed cellularity
0.003 0.997 0.000
H69.9 Eustachian tube disorder, unspecified
0.000 0.997 0.003
H70 Mastoiditis and related conditions
0.000 0.997 0.003
C82.3 Follicular lymphoma grade IIIa
0.003 0.997 0.000
G37.3 Acute transverse myelitis in demyelinating disease of central nervous system
0.003 0.997 0.000
H73.1 Chronic myringitis
0.000 0.997 0.003
M54.22 Cervicalgia (Cervical region)
0.003 0.997 0.000
C82.0 Small cleaved cell, follicular
0.003 0.997 0.000
C90.3 Solitary plasmacytoma
0.003 0.997 0.000
G37.5 Concentric sclerosis [Balo]
0.003 0.997 0.000
G37.4 Subacute necrotising myelitis
0.003 0.997 0.000
G37.2 Central pontine myelinolysis
0.003 0.997 0.000
G37.1 Central demyelination of corpus callosum
0.003 0.997 0.000
G37.0 Diffuse sclerosis
0.003 0.997 0.000
H72.8 Other perforations of tympanic membrane
0.000 0.997 0.003
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.997 0.003
T40.3 Methadone
0.000 0.997 0.003
M54.19 Radiculopathy (Site unspecified)
0.002 0.997 0.000
B96.5 Pseudomonas (aeruginosa)(mallei)(pseudomallei) as the cause of diseases classified to other chapters
0.003 0.997 0.000
C82.6 Cutaneous follicle centre lymphoma
0.002 0.997 0.000
C82.5 Diffuse follicle centre lymphoma
0.002 0.997 0.000
C82.4 Follicular lymphoma grade IIIb
0.002 0.997 0.000
C82.1 Mixed small cleaved and large cell, follicular
0.002 0.997 0.000
H68.1 Obstruction of Eustachian tube
0.000 0.997 0.003
T40.1 Heroin
0.000 0.997 0.003
C88.9 Malignant immunoproliferative disease, unspecified
0.002 0.997 0.000
C88.7 Other malignant immunoproliferative diseases
0.002 0.997 0.000
C88.3 Immunoproliferative small intestinal disease
0.002 0.997 0.000
C88.2 Gamma heavy chain disease
0.002 0.997 0.000
C88.1 Alpha heavy chain disease
0.002 0.997 0.000
T45.2 Vitamins, not elsewhere classified
0.000 0.997 0.003
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.997 0.002
T45.0 Antiallergic and antiemetic drugs
0.000 0.997 0.003
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.997 0.002
T46.7 Peripheral vasodilators
0.000 0.997 0.002
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.997 0.002
M54.14 Radiculopathy (Thoracic region)
0.002 0.997 0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.002 0.997 0.000
C90.0 Multiple myeloma
0.003 0.997 0.000
D18 Haemangioma and lymphangioma, any site
0.000 0.997 0.003
H68.0 Eustachian salpingitis
0.000 0.997 0.002
T40.4 Other synthetic narcotics
0.000 0.997 0.002
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.997 0.002
T45.4 Iron and its compounds
0.000 0.997 0.002
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.997 0.002
G36.0 Neuromyelitis optica [Devic]
0.002 0.997 0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.997 0.002
K75.9 Inflammatory liver disease, unspecified
0.002 0.997 0.000
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.997 0.002
T45.8 Other primarily systemic and haematological agents
0.000 0.997 0.002
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.997 0.002
T45.6 Fibrinolysis-affecting drugs
0.000 0.997 0.002
T45.3 Enzymes, not elsewhere classified
0.000 0.997 0.002
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.997 0.002
C79.8 Secondary malignant neoplasm of other specified sites
0.000 0.997 0.003
N18.2 Chronic kidney disease, stage 2
0.000 0.997 0.002
H67.8 Otitis media in other diseases classified elsewhere
0.000 0.997 0.002
H67.1 Otitis media in viral diseases classified elsewhere
0.000 0.997 0.002
H67.0 Otitis media in bacterial diseases classified elsewhere
0.000 0.997 0.002
H75.8 Other specified disorders of middle ear and mastoid in diseases classified elsewhere
0.000 0.997 0.002
H75.0 Mastoiditis in infectious and parasitic diseases classified elsewhere
0.000 0.997 0.002
T40.6 Other and unspecified narcotics
0.000 0.997 0.002
T45.1 Antineoplastic and immunosuppressive drugs
0.000 0.997 0.002
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.997 0.002
M54.10 Radiculopathy (Multiple sites in spine)
0.002 0.997 0.000
M54.96 Dorsalgia, unspecified (Lumbar region)
0.002 0.997 0.000
M54.90 Dorsalgia, unspecified (Multiple sites in spine)
0.002 0.997 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.